KLRK1 and colorectal carcinoma: For instance, in a human CRC NSG mouse model, NKG2D CAR-modified NKCs (NKG2D-DAP12CAR-NKCs) demonstrated enhanced IFN-γ secretion and a robust cytotoxic immune response, resulting in significant tumor suppression.